Literature DB >> 11307750

Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence.

P Scheid1, L Kempster, U Griesenbach, J C Davies, A Dewar, P P Weber, W H Colledge, M J Evans, D M Geddes, E W Alton.   

Abstract

It is unclear whether inflammation in the cystic fibrosis (CF) lung relates predominantly to bacterial infection, or occurs as a direct consequence of mutant cystic fibrosis transmembrane conductance regulator (CFTR) protein. Interleukin (IL)-8 secretion from CF and non-CF cell lines, and from CF and non-CF human primary nasal epithelial cells incubated with or without Pseudomonas aeruginosa, was measured. Activation of nuclear factor-kappaB (NF-kappaB) in unstimulated CF and non-CF nasal epithelial cells, cell lines and murine tissues was measured by gel-shift assays. No significant difference in basal IL-8 production or NF-kappaB activation was observed between CF and non-CF primary nasal cells. However, CF cells exhibited a significantly (p<0.01) increased IL-8 secretion following P. aeruginosa stimulation. Equalization of the increased P. aeruginosa adherence observed in CF cells, to non-CF levels, resulted in comparable IL-8 secretion. Further, IL-8 production did not differ with mutations which result in either correctly localized CFTR, or in partial/total mislocalization of this protein. Similar levels of NF-kappaB activation were observed in a number of organs of wildtype and CF mice. Finally, IL-8 secretion and NF-kappaB activity were not consistently increased in CF cell lines. Cos-7 cell transfection with plasmids expressing deltaF508 or G551D mutant CFTR protein resulted in increased activation of a p50-containing NF-kappaB complex, but IL-8 secretion was similar to wild-type cells. The authors conclude that the stimulus produced by Pseudomonas aeruginosa is the predominant inflammatory trigger in their models.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11307750     DOI: 10.1183/09031936.01.17100270

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  15 in total

1.  CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation.

Authors:  Torsten H Schroeder; Martin M Lee; Patrick W Yacono; Carolyn L Cannon; A Alev Gerçeker; David E Golan; Gerald B Pier
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

Review 2.  Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies.

Authors:  J Jacquot; M Delion; S Gangloff; J Braux; F Velard
Journal:  Osteoporos Int       Date:  2015-10-02       Impact factor: 4.507

Review 3.  Mechanisms of action and clinical application of macrolides as immunomodulatory medications.

Authors:  Soichiro Kanoh; Bruce K Rubin
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

4.  Effect of polarized release of CXC-chemokines from wild-type and cystic fibrosis murine airway epithelial cells.

Authors:  Michelle M Farberman; Aida Ibricevic; Theresa D Joseph; Kathryn T Akers; Raquel Garcia-Medina; Seth Crosby; Lane L Clarke; Steven L Brody; Thomas W Ferkol
Journal:  Am J Respir Cell Mol Biol       Date:  2010-07-16       Impact factor: 6.914

5.  In Vivo Proteome of Pseudomonas aeruginosa in Airways of Cystic Fibrosis Patients.

Authors:  Xia Wu; Richard J Siehnel; Jayanthi Garudathri; Benjamin J Staudinger; Katherine B Hisert; Egon A Ozer; Alan R Hauser; Jimmy K Eng; Colin Manoil; Pradeep K Singh; James E Bruce
Journal:  J Proteome Res       Date:  2019-05-22       Impact factor: 4.466

Review 6.  Monitoring inflammation in CF. Cytokines.

Authors:  Scott D Sagel; Frank J Accurso
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

7.  Myeloperoxidase-dependent oxidative metabolism of nitric oxide in the cystic fibrosis airway.

Authors:  Anna L P Chapman; Brian M Morrissey; Vihas T Vasu; Maya M Juarez; Jessica S Houghton; Chin-Shang Li; Carroll E Cross; Jason P Eiserich
Journal:  J Cyst Fibros       Date:  2010-01-15       Impact factor: 5.482

8.  TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells.

Authors:  Gerrit John; Ali O Yildirim; Bruce K Rubin; Dieter C Gruenert; Markus O Henke
Journal:  Am J Respir Cell Mol Biol       Date:  2009-06-05       Impact factor: 6.914

9.  The role of mean platelet volume predicting acute exacerbations of cystic fibrosis in children.

Authors:  Pιnar Uysal; Tuba Tuncel; Duygu Olmez; Arzu Babayigit; Ozkan Karaman; Nevin Uzuner
Journal:  Ann Thorac Med       Date:  2011-10       Impact factor: 2.219

10.  Reduced neutrophil elastase inhibitor elafin and elevated transforming growth factor-β1 are linked to inflammatory response in sputum of cystic fibrosis patients with Pseudomonas aeruginosa.

Authors:  Jan C Thomassen; Tobias Trojan; Maxine Walz; Christina Vohlen; Gregor Fink; Ernst Rietschel; Miguel A Alejandre Alcazar; Silke van Koningsbruggen-Rietschel
Journal:  ERJ Open Res       Date:  2021-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.